Our scientists take risks
Curiosity is our biggest asset. The freedom to explore leads to new discoveries.
Play
Play
Meet our scientists: Junyue Cao
“We focus here on cancer drug resistance, but the paper really starts from a broader question: once you know that a disease is associated with hundreds of genes, how do you design one therapy to target it?”
Read more:
Read more:
Meet our scientists: Nathaniel Heintz
"The disorders I'm most interested in involve changes in brain function that regulate either maladaptive human behaviors or late onset neurodeenerative disease."
Watch the video:
Watch the video:
Meet our scientists: Charles M. Rice
“For the first time, we have a system in which natural chronic viral infection drives liver cancer in an immunologically healthy animal, opening the door to studies and preclinical trials that simply weren’t possible before.”
Read more:
Read more:
Meet our scientists: Elaine Fuchs
"The findings could provide valuable inroads for developing new therapeutic strategies for chronic inflammation."
Read more:
Read more:
Get our newsletter
The latest science discoveries delivered monthly to your inbox.